Apimostinel plus brain training for depression
Part of Mental health clinical trials.
This study tests if a new drug called apimostinel, combined with computer-based brain training exercises, can improve depression symptoms. It may help people with major depression who also have negative thoughts about themselves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with major depression.
- Your depression symptoms are moderate to severe (score of 20 or higher on a depression scale).
- You have negative thoughts about yourself (based on questionnaires).
- You are willing to use effective birth control during the study (if applicable).
- You do not have certain other conditions like bipolar disorder or psychosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
This Phase 1 study uses a PET brain scan tracer to see how a specific brain target (PDE4B) is involved in major depressive disorder (MDD). It’s mainly testing whether the imaging approach works and what it shows in people with depression who meet specific safety and medication rules.
This trial tests whether a smartphone app combined with brain scanning (fMRI) can help people with depression. You will get real-time feedback on your brain activity to learn how to improve your mood.
This study tests a computer-based program called INCREM that helps improve thinking and memory skills in people with depression. If you have depression and notice trouble with concentration or daily tasks, this program may help you get back on track.
This study tests whether a combination of cognitive training (brain exercises) and a medication (guanfacine or sertraline) can improve thinking skills in people with depression. It involves MRI scans and computer tasks to understand how your brain responds.
This study tests if adding computer-based cognitive training to ketamine treatment can improve mood in people with depression that hasn't responded to other treatments. It aims to see if the combination works better than ketamine alone.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.